Status:
COMPLETED
Quadruple Fortified Salt Clinical Trial
Lead Sponsor:
Haydom Lutheran Hospital
Collaborating Sponsors:
University of Toronto
Tanzania Food and Drugs Authority
Conditions:
Anemia
Eligibility:
All Genders
18-49 years
Phase:
NA
Brief Summary
Anaemia is the world leading cause of disability and is responsible for about more than 115,000 maternal deaths and 591,000 perinatal deaths per year, of which 3/4 occur in Africa and Asia. Despite th...
Detailed Description
Anaemia is the low level of Haemoglobin based on the location. As per WHO a woman is termed anaemic if has HB \<11g/dl but in high attitude is =\<13g/dl
Eligibility Criteria
Inclusion
- Adult with relative low haemoglobin (Hb level 8g/dl to 13g/dl)
- Able to eat food cooked with salt
- Able to give consent
Exclusion
- Planning to become pregnant within the study period,
- chronically ill,
- have haematological diseases during study time,
- restricted to use salt in food
Key Trial Info
Start Date :
August 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT04404751
Start Date
August 23 2019
End Date
December 31 2020
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haydom Lutheran Hospital
Manyara, Tanzania